Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]
|
November 6, 2002
Histone deacetylation inhibitors
Andrea Ardizzoni, Maura Loprevite
Current Medicinal Chemistry. Anti-Cancer Agents
|
March 23, 2004
Farnesylated proteins as anticancer drug targets: from laboratory to the clinic
Patrizia Russo, Maura Loprevite, Alfredo Cesario, et al.
European Journal of Pharmacology
|
August 2, 2003
Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines
Alessandra de Cupis, Claudia Semino, Paolo Pirani, et al.
Oncology Reports
|
January 14, 2004
In vitro study of farnesyltransferase inhibitor SCH 66336, in combination with chemotherapy and radiation, in non-small cell lung cancer cell lines
Maura Loprevite, Roberto E Favoni, Alessandra De Cupis, et al.
Oncology Research
|
April 21, 2005
In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines
Maura Loprevite, Marcello Tiseo, Francesco Grossi, et al.
Anticancer Research
|
April 4, 2008
Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer
Marcello Tiseo, Andrea Ardizzoni, Mara Argenide Cafferata, et al.
Clinical Chemistry
|
June 25, 2005
Mutations in K-ras codon 12 detected in plasma DNA are not an indicator of disease in patients with non-small cell lung cancer
Sonya Trombino, Monica Neri, Riccardo Puntoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer
Maura Loprevite, Marcello Tiseo, Maurizio Chiaramondia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 2, 2008
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer
Marcello Tiseo, Marzia Capelletti, Giuseppe De Palma, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]
|
November 6, 2002
Histone deacetylation inhibitors
Andrea Ardizzoni, Maura Loprevite
Current Medicinal Chemistry. Anti-Cancer Agents
|
March 23, 2004
Farnesylated proteins as anticancer drug targets: from laboratory to the clinic
Patrizia Russo, Maura Loprevite, Alfredo Cesario, et al.
European Journal of Pharmacology
|
August 2, 2003
Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines
Alessandra de Cupis, Claudia Semino, Paolo Pirani, et al.
Oncology Reports
|
January 14, 2004
In vitro study of farnesyltransferase inhibitor SCH 66336, in combination with chemotherapy and radiation, in non-small cell lung cancer cell lines
Maura Loprevite, Roberto E Favoni, Alessandra De Cupis, et al.
Oncology Research
|
April 21, 2005
In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines
Maura Loprevite, Marcello Tiseo, Francesco Grossi, et al.
Anticancer Research
|
April 4, 2008
Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer
Marcello Tiseo, Andrea Ardizzoni, Mara Argenide Cafferata, et al.
Clinical Chemistry
|
June 25, 2005
Mutations in K-ras codon 12 detected in plasma DNA are not an indicator of disease in patients with non-small cell lung cancer
Sonya Trombino, Monica Neri, Riccardo Puntoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer
Maura Loprevite, Marcello Tiseo, Maurizio Chiaramondia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 2, 2008
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer
Marcello Tiseo, Marzia Capelletti, Giuseppe De Palma, et al.
Page
of 1